Instagram Pages

More Research Finds Low Awareness of Biosimilars Among Oncology Providers

NHS Provides Update on Biosimilar Adalimumab With a Focus on ISRs

E

ye on Pharma: Biocon Reports Its Highest-Ever Revenue and Profit Growth for Q3

R

eview Points to Nocebo Effect as a Cause of Higher Discontinuation Rates for Biosimilars

Coherus Settles With AbbVie, Sues Amgen, Over Biosimilar Adalimumab

I

ncreases in Insulin Prices Drove Spending Over 4 Years, Report Says

E

uropean Report Says M&As Affecting Biosimilars Need Scrutiny

Drugs Targeted by Biosimilars Are Responsible for Some of the Highest Hospital Spending

Sanctions Against Samsung BioLogics Suspended Pending Court Ruling

S

ales of Oncology Reference Products Far Outpace R&D Costs, Study Finds